If you are wondering, “How will iPS cells get to help patients?” part of the answer is perhaps the big player and Japanese Institution, Riken and its arm Retina Institute of Japan. The stem cell field is still abuzz about induced pluripotent stem (iPS) cells 7 years after their discovery. This amazing embryonic stem cell-like cells can …
Meet Retina Institute of Japan: translating iPS cells Read More »
A relatively newly recognized, important player in the stem cell field is a molecule called histone H3.3. Histones are key components of chromatin with integral roles in regulating almost all aspects of cell behavior through orchestrating functions such as transcription and chromosome segregation. Histone H3.3 knockout My lab has just (April 9) published new studies …
Histone H3.3: giving cells epigenetic flexibility Read More »
Below, guest blogger, John Carbona gives us his account (including pictures) of Day 2 of the Vatican Stem Cell Meeting, which included a talk by Nobel Laureate John Gurdon. Note, you can read John’s post on Day 1 of the meeting including more great pictures here. Friday, April 12, 2012 The Second International Vatican Adult …
John Carbona on Day 2 of Vatican Stem Cell Meeting including Gurdon Talk Read More »
Below are links to specific court documents and filings in stem cell-related legal proceedings. (I’ve also placed in parentheses links to my posts/analysis on these). Enjoy, especially you lawyers and investors. It’s a work in progress so expect more cases and documents to appear. In fact, if you have suggested additions please add them (plus …
The Catholic Church has long opposed embryonic stem cell research even as it has shown signs of getting more interested in adult stem cell research. I am an advocate of both types of research and both go on in my own lab. Now that we will have a new Pope this year, I wonder how …
Could new Pope equal new Vatican policy on stem cells? Read More »
I recently did a Q&A interview with NeoStem CEO Dr. Robin Smith. I posted Part 1 of that interview a few days ago here. Now we have part two focused on VSEL, ES cells, and iPS cells. PK: I frequently have readers of my blog ask questions about VSEL. They seem puzzled and unsure of …
Interview with NeoStem CEO Robin Smith Part 2: VSEL, ES cells, and iPS cells Read More »
I’ve already talked with science writer Ed Yong about the new Nature paper Araki, et al. (you can read Ed’s well-written piece here and you can another one on it by another one of my favorite writers, Monya Baker here), which suggests that iPS cells don’t trigger much in the way of an immune response. I …
Some thoughts on the Araki Nature iPS cell paper: an advance, but a few key caveats Read More »
In previous years I’ve done yearly predictions for the coming year’s events in the stem cell world (see predictions for 2011 and 2012 predictions). I did pretty well in my predicting stem cell events for this year (see analysis here) scoring a respectable 70%. Isn’t that a C-?,you might ask. No, when it comes to …
I recently did a text mining of all the article titles for Cell Stem Cell for 2012. The results were very insightful (expressed in a beautiful word cloud) for the journal and what are the top areas of focus of authors publishing there. I just did the same analysis for the journal Stem Cells and …
Text mining journal Stem Cells: intriguing comparison to Cell Stem Cell Read More »
Cell Stem Cell was the winner of my 2011 best stem cell journal award (see 2011 awards here, 2012 awards will be announced in early January). As I’ve “complained” in the past, the only thing I wish would be different is they’d publish even more articles per issue or per month! But what exactly does Cell …
Text mining Cell Stem Cell: surprising insights into the journal Read More »